This diabetes drug can lower the risk of kidney stones, gout: Study

A new study has found that SGLT-2 inhibitor drugs for type 2 diabetes may also reduce the risk of kidney stones and gout. These painful conditions are more common in people with diabetes. The drugs work by helping the body flush out excess fluid, which improves kidney function. A new study has found that SGLT-2 inhibitor drugs for type 2 diabetes may also reduce the risk of kidney stones and gout. These painful conditions are more common in people with diabetes. The drugs work by helping the body flush out excess fluid, which improves kidney function.  Health and Fitness, Health Tips, Exercises & Workout Tips, Diet & Wellness | Times of India Lifestyle